BAFNAPHARM

BAFNAPHARM · NSE · inactive

3.55

-0.15 (-4.05%)

as of 23 Aug 2019 close

Open

3.70

High

3.85

Low

3.55

Prev close

3.70

52w high

21.85

12 Sept 2018

52w low

3.55

23 Aug 2019

VWAP

3.71

Delivery %

—

n/a

Volume 4,503 · turnover ₹17,000 · NSE bhavcopy (official close) · history since 12 Nov 2012

Source: NSE equity master · as of 01 Apr 2019

Daily · NSE EOD

Exchange announcements

Source: NSE corporate filings · latest Today 13:28 IST

23 Apr 2019 19:10
Insider / SAST
The Promoter along with PAC has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019.
PDF · -
10 Apr 2018 16:12
Insider / SAST
Mahaveer Chand Bafna has submitted to the Exchange a copy of disclosure under Regulation 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
PDF · -
10 Apr 2017 19:43
Insider / SAST
Mahaveer Chand Bafna has has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
PDF · -
13 Apr 2016 18:57
Insider / SAST
Bafna Pharmaceuticals Limited has submitted to the Exchange vide letter dated April 7, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
PDF · -

Coming next in news

Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.